Your browser doesn't support javascript.
loading
Electrostatic anti-CD33-antibody-protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemia.
Bäumer, Nicole; Scheller, Annika; Wittmann, Lisa; Faust, Andreas; Apel, Mara; Nimmagadda, Subbaiah Chary; Geyer, Christiane; Grunert, Katharina; Kellmann, Neele; Peipp, Matthias; Kailayangiri, Sareetha; Gutierrez Suburu, Matias Ezequiel; Strassert, Cristian A; Schenk, Mathias; Greune, Lilo; Rüter, Christian; Dersch, Petra; Hartmann, Wolfgang; Rossig, Claudia; Neri, Dario; Müller-Tidow, Carsten; Schwöppe, Christian; Schliemann, Christoph; Khandanpour, Cyrus; Lenz, Georg; Berdel, Wolfgang E; Bäumer, Sebastian.
Affiliation
  • Bäumer N; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital of Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.
  • Scheller A; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital of Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.
  • Wittmann L; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital of Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.
  • Faust A; European Institute for Molecular Imaging, University of Münster, Waldeyerstr. 15, 48159, Münster, Germany.
  • Apel M; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital of Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.
  • Nimmagadda SC; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital of Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.
  • Geyer C; Institute for Clinical Radiology, University Hospital Münster, Albert-Schweitzer Campus 1, 48149, Münster, Germany.
  • Grunert K; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital of Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.
  • Kellmann N; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital of Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.
  • Peipp M; Division of Antibody-Based Immunotherapy, Christian-Albrechts-University, Arnold-Heller-Straße 3, 24105, Kiel, Germany.
  • Kailayangiri S; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.
  • Gutierrez Suburu ME; Department of Inorganic and Analytical Chemistry, University of Muenster, Corrensstraße 28/30, 48149, Münster, Germany.
  • Strassert CA; Department of Inorganic and Analytical Chemistry, University of Muenster, Corrensstraße 28/30, 48149, Münster, Germany.
  • Schenk M; Department of Drug Design and Target Validation, Fraunhofer Institute for Cell Therapy and Immunology IZI, Weinbergweg 22, 06120, Halle (Saale), Germany.
  • Greune L; Institute for Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Von-Esmarch-Str. 56, 48149, Münster, Germany.
  • Rüter C; Institute for Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Von-Esmarch-Str. 56, 48149, Münster, Germany.
  • Dersch P; Institute for Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Von-Esmarch-Str. 56, 48149, Münster, Germany.
  • Hartmann W; Gerhard-Domagk Institute for Pathology, University of Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.
  • Rossig C; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.
  • Neri D; Institute of Pharmaceutical Sciences, ETH Zurich, Vladimir-Prelog-Weg 1-5/10, 8093, Zurich, Switzerland.
  • Müller-Tidow C; Department of Medicine V, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Schwöppe C; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital of Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.
  • Schliemann C; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital of Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.
  • Khandanpour C; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital of Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.
  • Lenz G; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital of Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.
  • Berdel WE; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital of Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.
  • Bäumer S; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital of Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany. baumers@uni-muenster.de.
J Hematol Oncol ; 15(1): 171, 2022 12 01.
Article in En | MEDLINE | ID: mdl-36457063
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protamines / Leukemia, Myeloid, Acute Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protamines / Leukemia, Myeloid, Acute Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication: